of injectable artesunate for severe malaria delivered since 2010, saving the lives of an estimated 950,000 additional vulnerable children compared with quinine treatment
in severe malaria case fatality demonstrated in a pilot project to expand access to life-saving medicine in Zambia
in P. vivax liver-stage assays led to the identification of several potential radical cure hits, with one series undergoing early optimization
There are currently no upcoming events.